Avapritinib Yields Improvements in Bone Density in Advanced Systemic Mastocytosis
Treatment with avapritinib was associated with dynamic changes in bone density based on lumbar T-scores among patients with systemic mastocytosis.
Treatment with avapritinib was associated with dynamic changes in bone density based on lumbar T-scores among patients with systemic mastocytosis.
Frontline dostarlimab plus chemotherapy has been approved in the EU for all adult patients with primary advanced or recurrent endometrial cancer.
The proportion of oncology fellows who reported feeling professional burnout fell from 34% in 2013 to 20% in 2023. US oncology fellows in training experienced…
The FDA has granted 510(k) clearance for the Ventana Kappa and Lambda Dual ISH mRNA Probe Cocktail, an assay designed to assist pathologists in diagnosing…
The ACR-368 OncoSignature assay has received breakthrough device designation from the FDA for use in endometrial cancer.
Arce-Gallego et al. integrate next-generation sequencing with a RAD51 immunofluorescence assay to assess HRR function in advanced prostate cancer. They link RAD51-IF scores to mutations in…
Breelyn Wilky, MD, discusses the importance of disease screening and early diagnosis in the treatment of patients with sarcoma.
Arturo Loaiza-Bonilla, MD, discusses artificial intelligence in cancer care and clinical trials.
The addition of pembrolizumab to preoperative radiation therapy followed by surgery prolonged DFS in patients with soft tissue sarcoma of the extremity.
More than 2 million new cases of cancer will be diagnosed in the US this year, and more than 600,000 people will die of cancer,…
Early palliative care reduces invasive interventions and enhances comfort at EOL for CRC patients, according to real-world study results.